Tanzania Health Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Evaluation of Molecular Point-of-care Xpert ® Xpress SARS-CoV-2 Detection Implementation in Resource-limited Settings
Condition: Screening of Patients With Symptoms Suggestive of SARS-CoV-2 Infection Intervention: Device: Gene Expert molecular Point-of-Care (POC) (Xpert® Xpress SARS-CoV-2/Flu/RSV test Sponsors: National Institute for Medical Research, Tanzania; University of Kinshasa (UNIKIN), Congo, The Democratic Republic of the ( Prof Vivi Maketa); Research Institute for Health Sciences - Burkina Faso, Burkina Faso (Dr Marc Christian Tahita); Universiteit Antwerpen, Belgium (ProfJean-P ierre Van geertruyden); Københavns Universitet (UCPH), Denmark (Prof Michael Alifrangis); Universidad de Valencia, Spain ...
Source: ClinicalTrials.gov - August 25, 2022 Category: Research Source Type: clinical trials

Evaluation of Molecular Point-of-care Xpert ® Xpress SARS-CoV-2 Detection Implementation in Resource-limited Settings
Condition: COVID-19 Intervention: Device: Gene Expert molecular Point-of-Care (POC) (Xpert® Xpress SARS-CoV-2/Flu/RSV test Sponsors: National Institute for Medical Research, Tanzania; University of Kinshasa (UNIKIN), Congo, The Democratic Republic of the ( Prof Vivi Maketa); Research Institute for Health Sciences - Burkina Faso, Burkina Faso (Dr Marc Christian Tahita); Universiteit Antwerpen, Belgium (ProfJean-P ierre Van geertruyden); Københavns Universitet (UCPH), Denmark (Prof Michael Alifrangis); Universidad de Valencia, Spain (Prof Fernando Gonzalez-Candelas) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2022 Category: Research Source Type: clinical trials